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Three novel neuropeptides. Isolated from gangha of the Afrtcan grant snail. Aclzutmajirllcu, were named WWamtde-I. -2 and -3 These substances 
were btologtcally active heptapeptide amides with a Trp residue at both the N- and C-termmi. WWamide-I. which dtsplayed an inhtbitory acttvity 
on a central neuron of the snarl. exhibited pertpherally modulatory effects on muscular contracttons of not only the gut and other tissues of the 
snail but also certain ttssues of other molluscs. 
Molluscan neuropepttde; Neuromodulatory effect, .4c/r~tr1~ufir/icu 
1. INTRODUCTION 
It seems general that invertebrate muscles are regu- 
lated by multiple types of neurons which release multi- 
ple species of neuromediators. For instance, the ante- 
rior byssus retractor muscle (ABRM) of the bivalve 
mollusc. Mlytilus edulis, has been suggested to be con- 
trolled by at least seventeen peptide substances in addi- 
tion to five biogenic amines [I]. Therefore, it has been 
indispensable to isolate and characterize neuroactive 
peptides for understanding neuronal control of inverte- 
brate muscles. Since the isolation of FMRFamide in 
1977 by Price and Greenberg [3], a large number of 
neuropeptides have been isolated from molluscs. Ac- 
cording to the structure and action of the peptides. most 
of them could be classified into several groups such as 
Mlgtilzts inhibitory peptide (MIP), myomodulin-CARP, 
buccalin and small cardioactive peptide families [3]. 
However, certain peptides were found to have unique 
structural features. The most notable examples were 
achatin-I [4] and fulicin [5] which were isolated from 
ganglia of the African giant snail, Achatimt jiilicu. Each 
peptide contained a p-amino acid residue at the second 
position from N-terminus. We have been screening neu- 
ropeptides in the ganglia of A. ,fifirlicn since 1990 using 
Correspon&ce at/drew H. Mmakata. Suntory Institute for Bloor- 
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Abhueviafrons CARP, catch-relaxing peptide; TFA. trifluoroacetrc 
actd; Trts. trts(hydroxymethyl)ammomethane; HEPES, 4-(2-hy- 
droxyethyl)-I-prperazineethanesulfomc acrd: HPLC. hrgh perform- 
ance hqmd chromatography: SIMS. secondary ton mass spectrometry: 
FAB-MS, fast atom bombardment mass spectrometry: ACh. ace- 
tylcholine. 
the electrically evoked phasic contraction of ABRM of 
A4. edztlis as a bioassay system. In the present experi- 
ments. three novel homologous peptides with distinct 
structural features were isolated. Each peptide had a 
Trp residue at both the N- and C-termini. We report the 
structures and neuromodulatory effects of the peptides 
on certain tissues of molluscs. 
2. MATERIALS AND METHODS 
z I Purrfmtrot1 
Cerebral and suboesophageal ganglia of A jirlicu were excised from 
1.250 spectmens. The pangha were homogenized and extracted with 
100% acetone at 0°C. After centrtfugation at 16.000 x g for 40 mm, 
the pellet was extracted twrce with 80% acetone. Extracts were pooled 
and condensed mto 1 ml m vacua prior to dilutton with 0.1 N HCI 
After repeating centrifugatron (16.000 x g) of the suspenston, the su- 
pernatant was passed through five Scp-Pal\ Cl8 cartrtdges in series. 
The retamed material was washed wtth 0 I% TFA and eluted wnh 
0 1% TFA-methanol before the eluent was condensed in vacua. The 
restdue was dissolved m 0.1% TFA and frdcttonated by HPLC. Each 
fraction was assayed on the phastc contracttons evoked by electrical 
sttmulatrons of the ABRM of ,Zf e&l~ Expertmental procedures of 
the assay were simrlar to those described prevtously [6]. On elutton by 
a reversed-phase column (Asahipak ODP-50) wtth a 1X-min gradient 
of 0 to 60% acetomtrtle in 0 1% TFA. four Inhibitory peaks were 
obtained. The third peak was drvided into three parts by a strong acid 
ion-exchange column (TSKgel SP-SPW) wrth a 70-min gradient of 0 
to 0.7 M NaCl m 10 mM phosphate buffer (pH 6 9). Each part was 
further separated by a reversed-phase column (TSKgel ODS-ROT,) 
with a 50-mm grddtent of I8 to 28% acetonitrile m 0.1% TFA. and 
three Inhibitory peaks were obtained They were further purttied by 
the same column wtth isocratic elutton rattos of 23, 23.5 and 22.5% 
acetomtrrle m 0.1% TFA and were named WWamide-1. -2 and -3, 
respecttvely. WWamtde-I. -2 and -3 were thus purtfied. 
2.2 Strul~turc~ cietm~rmufron unrl clwtllr\rr 
WWamide-I, -2 and -3 were sequentially determined by an ammo 
actd analyzer (Tosoh CCP-8000) and a protein sequencer (Shimadzu 
104 
Volume 323, number 1,2 FEBSLETTERS May 1993 
PSQ-1 protein sequencer). Their molecular weights were determined 
by liquid SIMS (Hitachi M-80B) and FAB-MS (JEOL JMS-HXl101 
110A). According to the antictpated nomenclature, WWamide-1 was 
synthesized by a conventtonal solid-phase method (Applied B~osys- 
terns Inc. Model 430A peptide synthesizer). The WWamide-1 prepara- 
tion was subjected to structural confirmation, and its biological activ- 
ities were examined. 
2.3. Biological activity 
The activttres of WWamide-1 were examined on vartous neurons 
and muscles. The former cells were composed of the periodtcally 
oscillating neuron (PON), tonically autoactive neuron (TAN), dorsal 
right cerebral dtstinct neuron (d-RCDN), Bl and B4 neurons of A. 
fulrca [7,8]; and the latter tissues mvolved the crop [9], penis retractor 
and radula retractor muscles [5] of A fulrcu. ABRM of M. edulis [6] 
and radula protractor muscle of R. thomusruna [lo]. Electrical activi- 
ties of the neurons were recorded by an mtracellular microelectrode 
method 183. Methods for stimulatmg each muscle and recording the 
tension were described in previous papers [5.6,9,10], respectively. 
FMRFamide and ACh were used to elicit contractions of ABRM. 
whereas ACh and Glu were employed for the radula protractor muscle 
of R thomastuna. The composttion of artifictal seawater (ASW) used 
for ABRM of M rdulu was as follows: 445 mM NaCl, 55 mM MgCl,, 
10 mM CaC12, 10 mM KCl. 10 mM Tris-HCI (pH 7.8). However, 
physiologtcal saline used for A. fidica was of a dtfferent compositton: 
61 mM NaCl, 3.3 mM KC), 10.7 mM CaCI?, 13 mM MgCI,. 5 mM 
glucose. 10 mM HEPES-NaOH (pH 7.5). Two types of ASW contam- 
ing low (20 mM) and htgh (100 mM) concentrations of MgCIZ were 
used for the muscle of R. thomuslanu. 
WWamide-2 
WWamide-3 
Ser 36.5 (0.88) 1 Trp 15.3 963 (observed)b 
Glx 45.5 (1.10) 2 Lys 25.1 963 (calculated)’ 
Val 28.0 (0.68) 3 Gln 17.9 
Met 40.9 (0.99) 4 Met 19.1 
Lys 41.4 (1.00) 5 Ser 28.4 
6 Val 17.5 
7 Trp 3.0 
“Liquid SIMS; ‘FAB-MS; ‘calculated for the C-terminal amtde peptrdes. 
\\‘W:lmlde-I \VWXllldC-2 
Fig. 1. Effects of native WWamides on t’ he : phasic contractions of 
ABRM of M rrluks. Dose of WWamtde-1 and -2 applied to the muscle 
corresponded to 24 ganglia/ml medium, and that of WWamide-3 was 
adjusted to 3 gangha/ml medium. The pepttdes inhtbited phasic con- 
tractions of the muscle evoked by direct repetittve electrical stimula- 
tton (15 V, 3 ms, 10 Hz, 50 pulses) at lo-mm intervals. 
3. RESULTS AND DISCUSSION 
Purified WWamide-1, -2 and -3 showed an inhibitory 
effect on the phasic contractions of ABRM (Fig. 1). The 
results of amino acid and sequence analyses, liquid 
SIMS and FAB-MS are shown in Table I. Peaks of the 
molecular ions illustrated the presence of a C-terminal 
amide in the peptides. The primary structures inferred 
Table I 
Structural analysis of the purified pepttdes 
WWamide-1 
Amino acid analysts 
pm01 
Ser 251.3 (0.85) 
Glx 297.7 (1 .OO) 
Val 201.4 (0.68) 
Met 290.8 (0.98) 
Lys 296.3 (1 .OO) 
Cycle # 
1 
2 
3 
4 
5 
6 
7 
Sequence analysis 
Trp 
Lys 
Glu 
Met 
Ser 
Val 
Trp 
pm01 
69.0 
94.1 
49.9 
97.1 
97.5 
63.9 
21.3 
MS 
(M + H)’ 
964 (observed) 
964 (calculated) 
Ser 
Glx 
Val 
Met 
Arg 
24.8 (0 86) 
29.9 (1.04) 
16.7 (0.58) 
24.9 (0.86) 
28 8 (1.00) 
1 Trp 13.2 
2 Arg 5.0 
3 Glu 9.9 
4 Met 24 6 
5 Ser 26.4 
6 Val 12.6 
7 Trp 28 
992 (observed)b 
992 (calculated) 
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0 20 40 ml” 0 ‘0 4l,lllrl 
Fig. 2. HPLC profiles and dose--response relationshlp of the natlbe (NP) and synthetic (SP) WWamlde-1. (A) Elution with the cation exchange 
column was performed at a 20-min gradient of 0 to 0.2 M NaCl in 10 mM phosphate buffer (pH 6.9) (B) The reversed-phase column was eluted 
isocratlcally with 23.5% acetomtrile in 0.1% TFA (pH 2.2). (C) Dose-response relationshlp for native and synthetic WWamide-1 on the phasic 
contractions of ABRM in response to repetitive electrical stimulations ( 15 V, 3 ms, 10 Hz, 50 pulses. IO-min mterval). The decreased phasic 
contractlon was expressed as a percentage of the control peak tenslon. 
by the analysis were as follows: H-Trp-Lys-Glu-Met- 
Ser-Val-Trp-NH, (WWamide-1), H-Trp-Arg-Glu-Met- 
Ser-Val-Trp-NH, ( WWamide-2) and H-Trp-Lys-Gln- 
Met-Ser-Val-Trp-NH, (WWamide-3). As each peptide 
had a Trp residue at both the N- and C-termini, the 
peptides were named WWamide-1, -2 and -3. The se- 
quences were not related to those of any known pep- 
tides. The structure and biological activities between the 
native and synthetic WWamide-1 were compared, and 
confirmed by observing their HPLC illustrations and 
effects on ABRM (Fig. 2). 
The percentage of Trp contained in these peptides 
and proteins was the least among the 20 proteinous 
amino acids. However, the functional roles of Trp resi- 
dues are extremely important in keeping conformation 
and thus exhibiting biological activity. Activities of the 
synthetic WWamide-1 on several neurons (PON, TAN, 
d-RCDN. Bl and B4) and three muscles (crop, penis 
retractor and radula retractor muscles) of A. julica were 
examined. WWamide-1 inhibited the neuronal spike 
with a remarkable hyperpolarization in the d-RCDN, 
which is one of a pair of cerebral neuron cells, at 
2 x lo-’ M (Fig. 3A). However, the other neurons did 
not respond to the peptide at all. Since brain peptides 
have been known to affect activities of the gut, effects 
of the peptide on snail crop were investigated. WWa- 
A 
Xl mV 
t4tJ- t 
I O~hhl 105M IO~Jhl 
WWamtdc-1 
b 
J- - 
1 mln 
IL al iI_ ‘P 
t J 
10.‘M 
1 mm 
Fig 3. Effects of WWamide-I on a neuron and muscles of A julica. (A) Effect of 2 x lo-’ M WWamlde-1 on the spontaneous actlvlty of d-RCDN. 
(B) Effect of IO-” M WWamlde-1 on the spontaneous contractions of crop. (C) Dose-dependent actlvltles of WWamide-1 on the tetanic contractions 
ofpenis retractor muscle evoked by repetitive electrical stimulations (17 V. 0.8 ms. 40 Hz for I s). (D) Dose-dependent potentlatlons of WWamlde-1 
on the tetanic contractions of radula retractor muscle evoked by repetltlve electrical stimulations (12 V, 0.6 ms. 40 Hz for I s). 
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10 *hl 
WWamtde-1 
4z 
C 
2 mm 
IO “hl 
WWamlde- 1 
2 mm IVhhl 
WWamlde- 1 
Ftg. 4. Effects of WWamide-1 on ABRM of M rdulis. (A) Dose-dependent inhtbittons of WWamtde-1 on the phasic contractions in response to 
repetttive electrical sttmulations (15 V, 3 ms, 10 Hz, 50 pulses, IO-min interval). (B) Effect of 10m6 M WWamide-1 on muscular contracttons induced 
by lo-’ M ACh. (C) Effect of 10m6 M WWamide-1 on contractions induced by 10m6 M FMRFamide. 
mide-1 inhibited spontaneous contractions of the crop 
with a threshold of lo-’ M (Fig. 3B). At 10m6 M or 
higher, WWamide-1 potentiated the electrically evoked 
tetanic contractions of the penis retractor and radula 
retractor muscles (Fig. 3C.D). These results suggest that 
WWamide-1 may play a role in the central and periph- 
eral nervous systems of snail. WWamide-1 may be a 
useful tool for investigating the physiological relation- 
ships between the d-RCDN and examined muscles. For 
pharmacological studies on WWamide- 1, we employed 
the ABRM of M. e&/is [l] and radula protractor mus- 
cle of R. thomasiana [lo-121 because their pharmacol- 
ogical backgrounds have been investigated in detail. At 
concentrations of lo-* to 10m6 M, WWamide-1 dis- 
played a dose-dependent inhibition on the phasic con- 
10’hl 
WWamlde-1 
WWamtde-1 
tractions of ABRM of A4. edulis (Fig. 4A). However, the 
peptide at 10m6 M did not affect contractions evoked by 
either 10-j M ACh or 10e6 M FMRFamide (Fig. 4B,C). 
Since ACh and FMRFamide are thought to act on the 
post-synaptic sites of ABRM [l], these results suggest 
that the peptide acts pre-synaptically to inhibit neu- 
romuscular transmission. WWamide-1 exhibited 
marked excitatory effects on the radula protractor mus- 
cle of R. thomasiana. Although both ACh and Glu 
evoke muscular contractions by acting directly on mus- 
cle fibres, the principal excitatory neurotransmitter has 
been suggested to be ACh [ 111. The peptide potentiated 
muscle twitches at 10d9 M or higher and caused repeti- 
tive vigorous contractions after each twitch at lo-’ M 
in the low-magnesium (20 mM MgClJ ASW (Fig. 5A,). 
J 4’ 4’ J ’ 
10 ‘bl 1 min 
WWamlde-1 
_ fl+, 
4 
IO ‘hl 
1 mm 
WWamtde- 1 
lg 
Fig. 5. Excitatory activities of WWamide-1 on the radula protractor muscle of R thomasuzna. (A,) Effect of lo-’ M WWamide-1 on twitch 
contractions (15 V, 2 ms, 0.2 Hz, 5 pulses) in low-magnesium (20 mM MgCl,) ASW. (AZ) Effect of lo-’ M WWamrde-1 on twitch contractions 
(15 V, 5 ms, 0.2 Hz, 5 pulses) in htgh-magnesium (100 mM MgCL) ASW. (B,) Effect of lo-’ M WWamide-1 on contracttons Induced by 1O-6 M 
ACh in low-magnesium (20 mM MgCIJ ASW. (B?) Effect of lo-’ M WWamide-1 on contractile effects of 10m4 M Glu in low-magnesmm (20 mM 
MgC&) ASW. (Note: Glu induced contractions at 10e3 M in the preparation.) 
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To investigate if the effect was attributed to either pre- 
or post-synaptic action, the following experiments were 
performed. The electrical pulses (15 V, 2 ms, 0.5 Hz, 5 
pulses) used in Fig. 5A, are considered to cause contrac- 
tions by stimulating both the nerve and muscle fibres 
[lo]. When the concentration of MgCl, was increased to 
100 mM, magnesium ions blocked the neuromuscular 
transmission, and stimuli of longer duration pulses (5 
ms) elicited muscular contractions (Fig. 5AJ probably 
by direct stimulations of the muscle fibres [12]. Under 
such conditions, 10d7 M WWamide-1 potentiated the 
contractions although the magnitude of potentiation 
was smaller than that in Fig. 5A,. This result suggests 
that the peptide acts on the post-synaptic membrane to 
potentiate contractions of the muscle. The post-synaptic 
action of the peptide was further supported by the ef- 
fects on ACh- and Glu-induced contractions. The pep- 
tide potentiated ACh-induced contractions of the mus- 
cle (Fig. 5B,) at 10m7 M. Although lo-’ M Glu per se 
did not produce any contractions in this muscle without 
the peptide, marked contractile responses to a similar 
Glu concentration were elicited in the presence of the 
peptide (Fig. 5B,). 
WWamide-1 demonstrated inhibitory activities on 
the d-RCDN of A. jiilica. In the peripheral nervous 
systems of the snail and other molluscs, the effects were 
modulatory; either inhibitory or potentiating on the 
muscular contractions. Since WWamide-1 displayed 
such activities on several molluscan muscles, WWa- 
mides and/or related peptides might be distributed ex- 
tensively in molluscs and play roles in controlling mus- 
cular contractions. 
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